E Schauenstein1, H Rabl, W Steinschifter
1Department of Biochemistry, University of Graz, Austria.
A decrease in immunoglobulin G1 (%IgG1) and increase in %IgG2 serum levels can serve as an early diagnostic marker for colorectal carcinoma. This immune signature shows 88% specificity and 74% sensitivity in distinguishing patients from healthy individuals.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: